DCM
EDIT icon

Delpha Capital Management’s Editas Medicine EDIT Stock Holding History

Delpha Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-319
Closed -$10K – 431
2017
Q4 		$10K Buy
+319
New +$8.03K 0.01% 1062

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Delpha Capital Management's EDIT Position: Q1 2018 in Review

Delpha Capital Management sold out of Editas Medicine (EDIT) in Q1 2018, closing a stake of 319 shares — an estimated $10K sold.

Delpha Capital Management first reported a position in EDIT in Q4 2017 and held it in 1 quarter. The position peaked at $10K in Q4 2017. 197 funds tracked by Wall St. Rank hold EDIT as of Q1 2018.

  • Delpha Capital Management reported no remaining Editas Medicine position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 319 Editas Medicine shares in Q1 2018, an estimated $10K.
  • Delpha Capital Management first reported a position in Editas Medicine in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Editas Medicine position peaked at $10K in Q4 2017.
  • 197 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.